UTHSCSA Faculty Profiles v1.0
Qunibi, Wajeh Y
School of Medicine
Medicine
(210) 358-2962
qunibi@uthscsa.edu
|
|
| 9/2004 - Present |
Professor of Medicine |
University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 3/2001 - Present |
Medical Director |
University Hospital, Inpatient Hemodialylsis Unit, Inpatient Hemodialylsis Unit, San Antonio, TX |
| 6/1999 - Present |
Medical Director |
University Dialysis Northwest Unit, Dialysis Unit, San Antonio, TX |
| 6/1999 - Present |
Attending Nephrologist |
University Hospital, San Antonio, TX |
| Year |
Degree |
Discipline |
Institution |
| 1972 |
MD |
Medicine (with Honors) |
Alexandria University School of Medicine
Alexandria , Egypt |
| 1966 |
|
Science |
Alexandria University School of Medicine
Alexandria , Egypt |
| |
Residency |
Internal Medicine |
Union Memorial Hospital-Johns Hopkins Hospital
Baltimore , MD |
| |
Internship |
Internal Medicine |
Union Memorial Hospital-Johns Hopkins Hospital
Baltimore , MD |
| |
Clinical Fellowship |
Nephrology |
Baylor College of Medicine
Houston , TX |
Research Interest -
My research is focused on cardiovascular disease in patients with Chronic Kidney Disease. In particular, I have major interest in hyperphosphatemia of chronic kidney disease, renal osteodystrophy, vitamin D deficiency and cardiovascular calcification. I have also conducted studies on treatment of anemia of patients with chronic kidney disease with IV iron and ESA therapies. I have also been involved in recent clinical trials using ZS-9 for treatment of hyperkalemia. I have published book chapters and numerous articles, reviews and editorials. I also serve as a reviewer for several scientific journals including Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, Kidney International, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, Hemodialysis International, and BMC Nephrology. I have contributed 7 chapters in UpToDate. |
| Date |
Description |
Institution |
# Students |
| 9/2007 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 7/1999 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 7/1999 - Present |
Rotation Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 7/1999 - Present |
Lecture to Second Year Medical Students |
University of Texas Health Science Center at San Antonio |
|
| One, 2 hour lecture a year since 1999 |
Editorial |
| Qunibi WY. Is It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD J Am Soc Nephrol 2015 Mar;.
|
Electronic/Web Publication |
| Qunibi WY. Prescribing and assessing adequate hemodialysis 2017 Jan. |
| Qunibi WY. Aluminum toxicity in end-stage renal disease 2017 Jan. |
| Qunibi WY. Protein intake in maintenance hemodialysis patients 2017 Jan. |
| Qunibi WY. Overview of Chronic Kidney disease-Mineral Bone Disorder (CKD-MBD) 2017 Jan. |
| Qunibi WY. Treatment of anemia in peritoneal dialysis patients 2017 Jan. |
Journal Article |
| Qunibi WY. Sodium Zirconium Cyclosilicate in Hyperkalemia N. Engl J Med. [Epub ahead of print]. N Engl J Med. 2015 Jan 15;372(3):222-31 2015 Jan;372(3):222-231.
|
| Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, Roger SD, Yang A, Lerma E, Singh B. Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia: The HARMONIZE Randomized Clinical Trial JAMA 2014 Dec;312(21):2223-2233.
|
| Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, Iftikhar H, Mangoo-Karim R, Martin ER, Martinez CO, Newman GE, Qunibi WY, Ross DL, Singh B, Smith MT, Butcher A, Koch TA, Goodnough LT. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial Nephrol Dial Transplant 2013 Aug;.
|
Private |
| Funding Agency |
Nabi Pharmaceuticals |
| Title |
EPIC (Effect of PhosLo on Phosphorous Levels in Chronic Kidney Disease): A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Study of Calcium Acetate (PhosLo) on Phosphorous Levels in Subjects with Stage 4 Chronic Kid |
| Status |
Active |
| Period |
7/2005 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
Luitpold Pharmaceuticals, Inc. |
| Title |
Comparison of the Safety and Efficacy of a Unique Intravenous Iron Preparation (VIT-45) versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease |
| Status |
Active |
| Period |
11/2005 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
ZS Pharma |
| Title |
Phase III multicenter, two-phase, multi-dose, prospective, randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of ZS(Microporous, Fractionated, Protonated Zirconium Silicate), and oral sorbent, in subjects with mild |
| Status |
Active |
| Period |
4/2013 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
